Prescient Therapeutics Limited (ASX: PTX)
Sector: Health Care
Market cap: A$61M (as of 2 Nov 2026)
Bio-pharmaceutical research and development investment.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 3 Sept 2020 | Mr Chris Retzos | Exit | — | Filing ↗ |
| 26 Aug 2020 | Australian Ethical Investment Limited | Entry | ?% → 6.900% | Filing ↗ |
| 13 Dec 2019 | Credit Suisse Holdings (Australia) Limited (on behalf of Credit Suisse Group AG and its affiliates) | Exit | — | Filing ↗ |
| 2 Dec 2019 | Credit Suisse Holdings (Australia) Limited (on behalf of Credit Suisse Group AG and its affiliates) | Entry | ?% → 5.17% | Filing ↗ |
| 6 Nov 2019 | UBS Group AG and its related bodies corporate | Exit | — | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 1 May 2025 | DR JAMES CAMPBELL | Bought 222,000 | Filing ↗ |
| 29 Apr 2025 | Ms Melanie Farris | Bought 250,000 | Filing ↗ |
| 14 Mar 2025 | Dr Gavin James Shepherd | Bought 614,092 | Filing ↗ |
| 30 Sept 2024 | Dr Gavin James Shepherd | Bought 235,908 | Filing ↗ |
| 26 Mar 2019 | DR JAMES CAMPBELL | Bought 178,125 Fully Paid Ordinary Shares | Filing ↗ |
Cash and runway
Ask about PTX in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has PTX raised money in the last year, and at what discount?
- What was PTX's latest cash position and runway?
Loading PTX…